CP
LGND icon

Castleview Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Castleview Partners’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,071
Closed -$58K – 685
2022
Q3 		$58K Buy
+1,071
New +$58K 0.06% 236